Market Scenario

The bioprocess technology market share is expected to reach USD 17,300 Million by 2030 at 7.1% CAGR during the forecast period 2022-2030. Bioprocess technology is a specific process in which complete living cells or their components (e.g. enzymes, bacteria, chloroplasts) are use to obtain desired products. It deals with development and designing of equipment and processes for the manufacturing of products such as pharmaceuticals, chemicals, nutraceuticals, agriculture, papers and polymers from biological materials for treatment of waste water. Increase in the demand of fermenters using for large scaler manufacturing and producing large amount of end products has great demand of bioprocess technology market report. New fermentation technology, microorganism and enzymes gives different taste and texture to the food prolonging their shelf life and more palatable and digestible has increased the demand for bioprocessing market. In agriculture field bioprocessing is in greater demand it provides scientists new ways to develop more nutritious crop varieties, higher yield, disease resistance crops which results in reduce the need of fertilizers and other expensive agriculture chemicals.

The increase in the demand for stem cell conservation and regenerative medicine, Bio medical engineering, Cancer therapy, Biotechnology in textile industry are major driving factors for bio process technology. According to Charloote Lozier Institute in 2014 nearly 20,000 adult stem cell transplants were performed in United States. Also for the patient suffering for multiple myeloma more than 30,000 bone marrow and umbilical cord transplantation were done from 2010 to 2014 which can promote to grow in forecasted year which will result in enhancing the bioprocessing technology market. According to India brand equity foundation organization (IBEF) Department of Industrial Policies and Promotion (DIPP), has stated that Indian food processing sector has reached around US$ 7.56 billion worth to Foreign Direct Investment (FDI) during the period of April 2000 to March 2017. Confederation of Indian Industry (CII) estimates that the food processing sector can reach US$ 33 billion of investment in come 10 years. National Institute of Biomedical Imaging and Bioengineering published that tissue engineering (Artificial skin and cartilage) and regenerative medicine, is a field which focuses on cures instead of treatment for complex or chronic diseases has a greater demand. Scaffold for regenerating new kidney, engineering mature bone stem cell use to treat genetic diseases. Additionally, innovation in product offering are likely to boost the bioprocess technology equipment. However, cost incurred in is technology, cost for new product development, societal concerns lower the growth of bioprocess technology market research. 

Bio-process Market-Competitive Landscape

The global bio process technology market overview is characterized by the presence of several well-established and small players, the market appears to be highly competitive and fragmented. Multinational players are increasingly expanding their regional footprint in the developing economy, making it difficult for regional vendors to compete with them, especially in terms of features such as product differentiation, diverse product portfolios, and quality. The well-established market players are engaged in strategic acquisitions, collaborations, partnerships, global expansion, and product launches to gain competitive advantage in this market and to maintain their market position. Global bio process technology market players are Merck Millipore (Germany), Thermo Fisher Scientific, Inc. (U.S.), Becton, Dickinson and Company (U.S.), Danaher Corporation (U.S.), Lonza Group AG (Switzerland), Sartorius Stedim Biotech S.A (France), Corning, Inc. (U.S.), GE healthcare(US), Catalent (US), Boehringer Inelheim (Germany), Bio-Rad Laboratories (U.S.), and Charles River Laboratories (U.S.), Serum Institute of India are some Prominent players in the market.

Regional Analysis

The American region is expected to be the leading region in the global digestible sensors market owing to presence of advanced technology and well-developed healthcare sector. On regional basis, American region is divided into North America and South America. North America dominates the market due to presence of developed countries like the US and high disposable income. Americas held the largest share of the medical bioprocess technology market. According, to NCBI U.S lead in process validation and Food and Drug Administration (FDA) which promotes the market in this region.

Europe is anticipated to be the second largest market for Bioprocess technology. According to National center of Biotechnology Information (NCBI) biotechnology product have grown approximately $100 million a year to $4 billion a year and expected to grow in coming years.

Asia-Pacific is expected to be the fastest growing market for the Bioprocessing  market during the forecast period. According to National center of Biotechnology Information Japan leads the market both in upstream and downstream processing.

Furthermore, the Middle East and Africa region holds the lowest market share. The market in the Middle.

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research Consulting Services.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street,5Th Floor, New York,

New York 10013

United States of America